You are here

  • Home
  • Archive
  • Volume 78, Issue 2
  • To switch or not to switch: results of a nationwide guideline of mandatory switching from originator to biosimilar etanercept. One-year treatment outcomes in 2061 patients with inflammatory arthritis from the DANBIO registry

Article metrics

Article menu

Download PDFPDF

Inflammatory arthritis
To switch or not to switch: results of a nationwide guideline of mandatory switching from originator to biosimilar etanercept. One-year treatment outcomes in 2061 patients with inflammatory arthritis from the DANBIO registry
Free

 

Online download statistics by month:

Online download statistics by month: November 2018 to March 2024

AbstractFullPdf
Nov 20183881474336
Dec 20181753507152
Jan 20191534276176
Feb 2019866192125
Mar 2019688144110
Apr 20193797881
May 20194787080
Jun 20193894848
Jul 20194605050
Aug 20193514439
Sep 20193606147
Oct 20194877660
Nov 20193627263
Dec 20192863839
Jan 20203644142
Feb 20203724433
Mar 20205013947
Apr 20201813421
May 20202563122
Jun 20202073330
Jul 202011311158
Aug 2020686727
Sep 202016015688
Oct 202011911666
Nov 2020949053
Dec 202011010860
Jan 202112111854
Feb 2021918238
Mar 2021907743
Apr 2021979145
May 202114814571
Jun 202112611954
Jul 202111210845
Aug 202112811444
Sep 202113812850
Oct 202111610462
Nov 202112911557
Dec 202112611937
Jan 202213213339
Feb 202210810529
Mar 202216715635
Apr 202219118240
May 202216115731
Jun 202213612648
Jul 202214113151
Aug 20221159930
Sep 202210610032
Oct 2022958429
Nov 202211110244
Dec 2022626022
Jan 2023968841
Feb 20231018922
Mar 2023957743
Apr 2023484222
May 2023726137
Jun 2023857830
Jul 2023685716
Aug 2023685526
Sep 2023908122
Oct 2023857121
Nov 2023787716
Dec 2023908623
Jan 2024676929
Feb 2024595129
Mar 2024795437
Total1894767913397